ACDIMA to increase investments in pharmaceutical companies
The Arab Company for Drug Industry and Medical Appliances (ACDIMA) is planning on increasing its investments in the pharmaceutical sector through buying new production lines or through leading a capital increase for promising companies, according to Chairman of the BoD, Olfat Ghorab. ACDIMA made another EGP100mn to the government-sponsored medicine development fund, bringing the total donations made thus far to EGP260mn, EGP200mn from ACDIMA and EGP50mn from EIPICO, according to the Ministry of Health and Population.
EIPICO: EGP120.10 as of 27 Nov. 2017, Rating: Neutral, TP: EGP115.00/share, MCap: USD539mn, PHAR EY/PHAR.CA
This website uses cookies to make the site work, to understand if the site is working well, how it is being used, to connect to social media sites (such as Facebook and Twitter) and to collect information useful to allow us and our partners to provide you with more relevant ads . Some cookies are essential to make the site work, but you can control how we use non-essential cookies at any time by clicking the “ON/OFF” button next to each category. For more information about the cookies used on this site, see Privacy Policy.
Decide which cookies you want to allow.
Strictly Necessary
These cookies are essential in order to enable you to move around our website and use its features, such as accessing secure areas of our website. Without these cookies, any services on our Site you wish to access cannot be provided.
Analytical/performance cookies
Visitors use our website, for instance which pages you go to most often, and if you get error messages from web pages.